| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2012-09-06 15:16:49 UTC |
|---|
| Update Date | 2021-09-14 14:58:19 UTC |
|---|
| HMDB ID | HMDB0014376 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Temazepam |
|---|
| Description | Temazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine that acts as a gamma-aminobutyric acid modulator and anti-anxiety agent. [PubChem]Benzodiazepines bind nonspecifically to benzodiazepine receptors, which affects muscle relaxation, anticonvulsant activity, motor coordination, and memory. As benzodiazepine receptors are thought to be coupled to gamma-aminobutyric acid-A (GABAA) receptors, this enhances the effects of GABA by increasing GABA affinity for the GABA receptor. Binding of the inhibitory neurotransmitter GABA to the site opens the chloride channel, resulting in a hyperpolarized cell membrane that prevents further excitation of the cell. |
|---|
| Structure | CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1 InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| Restoril | Kegg | | Hydroxydiazepam | HMDB | | Methyloxazepam | HMDB | | N-Methyloxazepam | HMDB | | Oxydiazepam | HMDB | | Apotex brand OF temazepam | MeSH, HMDB | | Katwijk brand OF temazepam | MeSH, HMDB | | Knoll brand OF temazepam | MeSH, HMDB | | Nocturne | MeSH, HMDB | | Normitab | MeSH, HMDB | | Novopharm brand OF temazepam | MeSH, HMDB | | Nu pharm brand OF temazepam | MeSH, HMDB | | Nu temazepam | MeSH, HMDB | | Nu-pharm brand OF temazepam | MeSH, HMDB | | PMS Temazepam | MeSH, HMDB | | PMS-Temazepam | MeSH, HMDB | | Remestan | MeSH, HMDB | | Sigma brand OF temazepam | MeSH, HMDB | | 3 Hydroxydiazepam | MeSH, HMDB | | 3-Hydroxydiazepam | MeSH, HMDB | | AHP brand OF temazepam | MeSH, HMDB | | apo-Temazepam | MeSH, HMDB | | Genopharm brand OF temazepam | MeSH, HMDB | | Genpharm brand OF temazepam | MeSH, HMDB | | Mallinckrodt brand OF temazepam | MeSH, HMDB | | Nortem | MeSH, HMDB | | novo Temazepam | MeSH, HMDB | | Nu-temazepam | MeSH, HMDB | | Orion brand OF temazepam | MeSH, HMDB | | Planum | MeSH, HMDB | | Tenox | MeSH, HMDB | | Wyeth brand OF temazepam | MeSH, HMDB | | CT-Arzneimittel brand OF temazepam | MeSH, HMDB | | apo Temazepam | MeSH, HMDB | | Euhypnos | MeSH, HMDB | | ICN brand OF temazepam | MeSH, HMDB | | Normison | MeSH, HMDB | | Norton brand OF temazepam | MeSH, HMDB | | Novartis brand OF temazepam | MeSH, HMDB | | Pfizer brand 1 OF temazepam | MeSH, HMDB | | Pfizer brand 2 OF temazepam | MeSH, HMDB | | Pharmascience brand OF temazepam | MeSH, HMDB | | Scheffler brand OF temazepam | MeSH, HMDB | | Signopam | MeSH, HMDB | | Tema, norkotral | MeSH, HMDB | | Temaze | MeSH, HMDB | | Temtabs | MeSH, HMDB | | CT Arzneimittel brand OF temazepam | MeSH, HMDB | | Alphapharm brand OF temazepam | MeSH, HMDB | | Dasuen | MeSH, HMDB | | Desitin brand OF temazepam | MeSH, HMDB | | Gen temazepam | MeSH, HMDB | | Gen-temazepam | MeSH, HMDB | | Levanxol | MeSH, HMDB | | Norkotral tema | MeSH, HMDB | | novo-Temazepam | MeSH, HMDB | | Pronervon T | MeSH, HMDB | | Temazep von CT | MeSH, HMDB | | Von CT, temazep | MeSH, HMDB |
|
|---|
| Chemical Formula | C16H13ClN2O2 |
|---|
| Average Molecular Weight | 300.74 |
|---|
| Monoisotopic Molecular Weight | 300.066555377 |
|---|
| IUPAC Name | 7-chloro-3-hydroxy-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
|---|
| Traditional Name | temazepam |
|---|
| CAS Registry Number | 846-50-4 |
|---|
| SMILES | CN1C2=C(C=C(Cl)C=C2)C(=NC(O)C1=O)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C16H13ClN2O2/c1-19-13-8-7-11(17)9-12(13)14(18-15(20)16(19)21)10-5-3-2-4-6-10/h2-9,15,20H,1H3 |
|---|
| InChI Key | SEQDDYPDSLOBDC-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzodiazepines |
|---|
| Sub Class | 1,4-benzodiazepines |
|---|
| Direct Parent | 1,4-benzodiazepines |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Aryl chloride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Tertiary carboxylic acid amide
- Carboxamide group
- Ketimine
- Lactam
- Alkanolamine
- Azacycle
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Carboxylic acid derivative
- Organic nitrogen compound
- Organohalogen compound
- Organochloride
- Imine
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organic oxygen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Not Available | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | 119 - 121 °C | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | 0.053 g/L | Not Available | | LogP | 3 | Not Available |
|
|---|
| Experimental Chromatographic Properties | Experimental Collision Cross Sections| Adduct Type | Data Source | CCS Value (Å2) | Reference |
|---|
| [M+H]+ | CBM | 166.1 | 30932474 |
|
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 5.51 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 14.2609 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.19 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 26.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized |
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Temazepam GC-MS (Non-derivatized) - 70eV, Positive | splash10-0076-1290000000-b5520ec3d2305756be73 | 2017-09-01 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Temazepam GC-MS (1 TMS) - 70eV, Positive | splash10-0kmr-9437000000-0244d11da064e8c0d1e6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Temazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Temazepam GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Temazepam GC-MS (TBDMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | | MS | Mass Spectrum (Electron Ionization) | splash10-00di-4391000000-eba55d0cdbd09c877424 | 2014-09-20 | Not Available | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QTOF , positive-QTOF | splash10-0udi-0019000000-f9c9fe92391b593143eb | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QTOF , positive-QTOF | splash10-0a4i-0091000000-b26b004678460e39d9db | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QTOF , positive-QTOF | splash10-0a4i-0090000000-d71ab75b6d551af5cf29 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QTOF , positive-QTOF | splash10-0a4i-0390000000-43e671827e9519f8cbd7 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QTOF , positive-QTOF | splash10-0a6r-0980000000-6fcab627ec42157d1ed9 | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam LC-ESI-QFT , positive-QTOF | splash10-0a4i-0092000000-36017deb260bb70b05cd | 2017-09-14 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 35V, Positive-QTOF | splash10-0a4i-0092000000-6a05dc5e5e75afdcbb8e | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 40V, Positive-QTOF | splash10-0a4i-0390000000-d827d877da314f89978b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 30V, Positive-QTOF | splash10-0a4i-0090000000-4d4b7b7e906e1e440ca6 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 10V, Positive-QTOF | splash10-0udi-0019000000-63de5541966279a763b9 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 20V, Positive-QTOF | splash10-0a4i-0091000000-6f9aea1c6f9196a6e83b | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 35V, Positive-QTOF | splash10-0a4i-0090000000-870c794aaa0e39428afa | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 50V, Positive-QTOF | splash10-0a6r-0980000000-66dedd2284e2508d3ac3 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 50V, Positive-QTOF | splash10-0a6r-0980000000-675aed8b116c38e11e48 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Experimental LC-MS/MS | LC-MS/MS Spectrum - Temazepam 50V, Positive-QTOF | splash10-0a6r-0980000000-5dbd9ed3345c15cac665 | 2021-09-20 | HMDB team, MONA | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 10V, Positive-QTOF | splash10-0udi-0009000000-7d9e12c41cdc37869173 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 20V, Positive-QTOF | splash10-0udi-0339000000-d65623eab9da4e6e0a8f | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 40V, Positive-QTOF | splash10-002f-3930000000-e6777c2ed8db44e9e193 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 10V, Negative-QTOF | splash10-0002-0090000000-7fc31b3910bb0c20262c | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 20V, Negative-QTOF | splash10-0007-0190000000-f5990016db4cbf3432da | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 40V, Negative-QTOF | splash10-052f-9340000000-37b87e4eed991dce5a03 | 2016-08-03 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 10V, Negative-QTOF | splash10-0002-0090000000-cde58810059d12ab5be7 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 20V, Negative-QTOF | splash10-0002-1090000000-2dc539ab79eba1a4f1d7 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 40V, Negative-QTOF | splash10-001i-9020000000-9bd67fa93999e29b9582 | 2021-09-22 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Temazepam 10V, Positive-QTOF | splash10-0udi-0039000000-3e8551a1d6ec2eac7db0 | 2021-09-23 | Wishart Lab | View Spectrum |
|
|---|